Abstract
Little is known about the growth-signaling pathways that govern the proliferation of Ewing tumor (ET) cells either in vitro or in vivo. We have studied signal transduction pathways in ET cell lines and compared kinase expression levels and proliferation rates with primary tumors. Cell lines were studied both as conventional adherent monolayers and as anchorage-independent multi-cellular spheroids. Importantly, we observed significant differences between these in vitro models and found that ET spheroids were more closely related to primary tumors with respect to cell morphology, cell–cell junctions, proliferative index and kinase activation. Monolayer ET cells demonstrated serum-dependent phosphorylation of ERK1/2 and AKT and constitutively high serum-independent cyclin D1 protein expression. However, when ET cells were placed in suspension culture, there was immediate serum-independent activation of ERK1/2 and AKT. In addition, cyclin D1 protein expression was completely blocked until stable multi-cellular spheroids had formed, indicating that cell–cell adhesion is necessary for the proliferation of anchorage independent ET cells. This reduction in cyclin D1 expression was post-transcriptional and could be mimicked in monolayer cells by treatment with phosphatidyl inositol-3 kinase (PI3K) inhibitors. Moreover, PI3K inhibition significantly reduced ET cell proliferation and, in primary ET samples, cyclin D1 expression correlated with expression of activated AKT. Thus, the PI3K–AKT pathway appears to be critical for the proliferation of ET cells both in vitro and in vivo and tumor cell growth in vivo may be better represented by the study of anchorage-independent multi-cellular spheroids.
Similar content being viewed by others
References
Assoian RK . 1997 J. Cell Biol. 136: 1–4
Baserga R . 1997 Exp. Cell Res. 236: 1–3
Bates RC, Edwards NS, Yates JD . 2000 Crit. Rev. Oncol. Hematol. 36: 61–74
Connell-Crowley L, Elledge SJ, Harper JW . 1998 Curr. Biol. 8: 65–68
Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA . 1995 Nature 378: 785–789
de Alava E, Panizo A, Antonescu CR, Huvos AG, Pardo-Mindan FJ, Barr FG, Ladanyi M . 2000 Am. J. Pathol. 156: 849–855
Delattre O, Zucman J, Ploustagel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G . 1992 Nature 359: 162–165
Diehl JA, Cheng M, Roussel MF, Sherr CJ . 1998 Genes Dev. 12: 3499–3511
Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME . 1997 Science 275: 661–665
Dunn T, Praissman L, Hagag N, Viola MV . 1994 Cancer Genet. Cytogenet. 76: 19–22
Gille H, Downward J . 1999 J. Biol. Chem. 274: 22033–22040
Girnita L, Girnita A, Wang M, Meis-Kindblom JM, Kindblom LG, Larsson O . 2000 Oncogene 19: 4298–4301
Hanks SK, Polte TR . 1997 Bioessays 19: 137–145
Hoshino R, Chatani Y, Yamori T, Tsuruo T, Oka H, Yoshida O, Shimada Y, Arii S, Wada H, Fujimoto J, Kohno M . 1999 Oncogene 18: 813–822
Kawamura K, Kobayashi Y, Tanaka T, Ikeda R, Fujikawa-Yamamoto K, Suzuki K . 2000 Anal. Quant. Cytol. Histol. 22: 107–113
Kopnin BP . 2000 Biochemistry (Mosc.) 65: 2–27
Kovar H, Aryee DN, Jug G, Henockl C, Schemper M, Delattre O, Thomas G, Gadner H . 1996 Cell Growth Differ. 7: 429–437
Kulik G, Klippel A, Weber MJ . 1997 Mol. Cell Biol. 17: 1595–1606
Lawlor ER, Lim JF, Tao W, Poremba C, Chow CJ, Kalousek IV, Kovar H, MacDonald TJ, Sorensen PHB . 1998 Cancer Research 58: 2469–2476
Liu JJ, Chao JR, Jiang MC, Ng SY, Yen JJ, Yang-Yen HF . 1995 Mol. Cell Biol. 15: 3654–3663
May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G, Denny CT . 1993 Proc. Natl. Acad. Sci. USA 90: 5752–5756
Mellin W, Dierschauer W, Hiddemann W, Roessner A, Edel G, Wuisman P, Harle A, Grundmann E . 1989 Curr. Top Pathol. 80: 115–152
Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N . 1998 J. Biol. Chem. 273: 29864–29872
Niggli FK, Powell JE, Parkes SE, Ward K, Raafat F, Mann JR, Stevens MC . 1994 Br. J. Cancer 69: 1106–1110
Ponten J . 1971 Spontaneous and Virus Induced Transformation in Cell Culture New York: Springer Verlag
Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P, Tennant RW, Weinberg RA, Yuspa SH, Conti CJ . 1998 Genes Dev. 12: 2469–2474
Rodriguez-Puebla ML, Robles AI, Conti CJ . 1999 Mol. Carcinog. 24: 1–6
Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD, Glass DJ . 1999 Science 286: 1738–1741
Roovers K, Assoian RK . 2000 Bioessays 22: 818–826
Sambrook J, Fritch EF, Maniatis T . 1989 Molecular cloning: a laboratory manual 2nd edn Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press
Santini MT, Rainaldi G . 1999 Pathobiology 67: 148–157
Santini MT, Rainaldi G, Indovina PL . 2000 Crit. Rev. Oncol Hematol 36: 75–87
Scheid MP, Woodgett JR . 2000 Curr. Biol. 10: R191–R194
Scotlandi K, Benini S, Sarti M, Serra M, Lollini P-L, Maurici D, Picci P, Manara MC, Baldini N . 1996 Cancer Res. 56: 4570–4574
Scotlandi K, Serra M, Manara MC, Maurici D, Benini S, Nini G, Campanacci M, Baldini N . 1995 Cancer 75: 806–814
Shao J, Sheng H, DuBois RN, Beauchamp RD . 2000 J. Biol. Chem. 275: 22916–22924
Sherr CJ . 2000 Cancer Res. 60: 3689–3695
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ . 2000 Trends Cell Biol. 10: 147–154
Silvany RE, Eliazer S, Wolff NC, Ilaria Jr RL . 2000 Oncogene 19: 4523–4530
Sorensen PHB, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT . 1994 Nature Genet 6: 146–151
Tanaka K, Iwakuma T, Harimaya K, Sato H, Iwamoto Y . 1997 J. Clin. Invest. 99: 239–247
Tapon N, Hall A . 1997 Curr. Opin Cell Biol. 9: 86–92
Toretsky JA, Kalebic T, Blakesley V, LeRoith D, Helman LJ . 1997 J. Biol. Chem. 272: 30822–30827
Toretsky JA, Thakar M, Eskenazi AE, Frantz CN . 1999 Cancer Res. 59: 5745–5750
Treinies I, Paterson HF, Hooper S, Wilson R, Marshall CJ . 1999 Mol. Cell Biol. 19: 321–329
Triche TJ . 1993 Principles and Practice of Pediatric Oncology Vol. 2: Pizzo, PA and Poplack DG. (eds) Philadelphia: J.B. Lippincott: pp. 115–152
van Weeren PC, de Bruyn KM, de Vries-Smits AM, van Lint J, Burgering BM . 1998 J. Biol. Chem. 273: 13150–13156
Vollmer E, Roessner A, Wuisman P, Harle A, Grundmann E . 1989 Curr. Top Pathol. 80: 91–114
Whang-Peng J, Triche TJ, Knutsen T, Miser J, Douglass EC, Israel MA . 1984 N. Engl. J. Med. 311: 584–585
Wong CW, Lee A, Shientag L, Yu J, Dong Y, Kao G, Al-Mehdi AB, Bernhard EJ, Muschel RJ . 2001 Cancer Res. 61: 333–338
Yee D, Favoni RE, Lebovic GS, Lombana F, Powell D, Reynolds CP, Rosen N . 1990 J. Clin. Invest. 86: 1806–1814
Zimmermann S, Moelling K . 1999 Science 286: 1741–1744
Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G, Delattre O . 1993 EMBO J. 12: 4481–4487
Acknowledgements
The authors wish to thank Joan Mathers, Heather Wildgrove, Shelley Moerike, Theresa Sturby and Sharon Middler for technical assistance and Drs Tim Triche and Chris Denny for cells and probes. This work was supported by a post-doctoral fellowship from the Medical Research Council of Canada (ERL) and funds from the Canadian Institutes for Health Research and the National Cancer Institute, Directors Challenge: Towards a molecular classification of tumors (vol-CA88199).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lawlor, E., Scheel, C., Irving, J. et al. Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in Ewing tumors. Oncogene 21, 307–318 (2002). https://doi.org/10.1038/sj.onc.1205053
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205053
- Springer Nature Limited
Keywords
This article is cited by
-
TrkC, a novel prognostic marker, induces and maintains cell survival and metastatic dissemination of Ewing sarcoma by inhibiting EWSR1-FLI1 degradation
Cell Death & Disease (2022)
-
Enhanced hexosamine metabolism drives metabolic and signaling networks involving hyaluronan production and O-GlcNAcylation to exacerbate breast cancer
Cell Death & Disease (2019)
-
Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids
Journal of Experimental & Clinical Cancer Research (2017)
-
Polycomb-dependent repression of the potassium channel-encoding gene KCNA5 promotes cancer cell survival under conditions of stress
Oncogene (2015)
-
The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting
British Journal of Cancer (2012)